Aptevo Therapeutics Inc APVO 深 滬
已收盤 09-12 16:00:00 美东时间
1.47
-0.030
-2.00%
華盛通- 最 高1.5424
- 今 開1.51
- 成交量 25.63万股
- 最 低 1.43
- 昨 收 1.50
- 總市值 483.32万
- 52周最高 381.10
- 市盈率 靜 --
- 換手率 7.80%
- 52周最低 1.43
- 委 比 95.32%
- 總股本 328.79万
- 歷史最高 3778913.60
- 量 比 1.12
- 振 幅 7.49%
- 歷史最低 1.43
- 每 手 1
- 風險率 73.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aptevo Expands Anti-Cancer Pipeline With Patents For APVO452, APVO451; Acute Myeloid Leukemia Candidate Mipletamig Shows Strong Clinical Validation
New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging tumor antigens, T cells, and immunosuppressive
09-04 20:50
Aptevo Unveils APVO442 Precision CD3 Bispecific For Prostate Cancer, Advancing Solid Tumor Strategy With CRIS-7 Platform
Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation in prostate cancer; part of Aptevo's growing CRIS-7-derived CD3
08-13 20:14
Aptevo Therapeutics Q2 EPS $(8.40) Beats $(83.20) Estimate
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(8.40) per share which beat the analyst consensus estimate of $(83.20) by 89.9 percent. This is a 99.32 percent increase over losses of $(1.24 thousand) per
08-11 20:10
Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance
Aptevo Therapeutics ( ($APVO) ) just unveiled an announcement. In response to a...
07-01 04:59
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
06-21 20:00
Aptevo Therapeutics Raises $7.45M Through Stock Sale
Aptevo Therapeutics ( ($APVO) ) has shared an update. On June 18, 2025, Aptevo ...
06-21 04:41
美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%
周三，Aptevo Therapeutics(APVO.US)飙升超130%，报6.52美元。
06-18 23:41
Aptevo Therapeutics Files Reasonable Best Efforts Public Offering Of Up To ~1.7M Shares And ~1.7M Pre-Funded Warrants With ~8.5M Common Warrants, Totaling Up To ~10.26M Shares At An Assumed Combined Public Offering Price Of $4.68 Per Share
Up to 1,709,401 Shares of Common StockUp to 1,709,401 Pre-Funded Warrants to Purchase up to 1,709,401 Shares of Common StockUp to 8,547,005 Common Warrants to Purchase up to 8,547,005 Shares of Common StockUp to
06-17 00:59
Aptevo Therapeutics Announces Reverse Stock Split
Aptevo Therapeutics ( ($APVO) ) has issued an update. On May 22, 2025, Aptevo T...
05-23 05:48
